Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Mike Kratky's Stock Ratings
Leerink Partners Analyst
Mike Kratky is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
32.1%
Smart Score
Overall Average Return Percentile
87th
Number of Ratings
42
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 10/01/2025 | BSX | Buy Now | Boston Scientific | $92.21 | 38.81% | $127 → $128 | Maintains | Outperform | Get Alert | |
| 08/15/2025 | INSP | Buy Now | Inspire Medical Systems | $119.26 | -18.67% | $116 → $97 | Maintains | Market Perform | Get Alert | |
| 08/05/2025 | INSP | Buy Now | Inspire Medical Systems | $119.26 | -2.73% | $149 → $116 | Maintains | Market Perform | Get Alert | |
| 07/14/2025 | INSP | Buy Now | Inspire Medical Systems | $119.26 | 24.94% | $176 → $149 | Maintains | Market Perform | Get Alert | |
| 06/16/2025 | BSX | Buy Now | Boston Scientific | $92.21 | 27.97% | → $118 | Initiates | → Outperform | Get Alert | |
| 06/16/2025 | MDT | Buy Now | Medtronic | $98.89 | 11.24% | → $110 | Initiates | → Outperform | Get Alert | |
| 05/05/2025 | INSP | Buy Now | Inspire Medical Systems | $119.26 | 47.58% | $194 → $176 | Maintains | Market Perform | Get Alert | |
| 02/24/2025 | BBNX | Buy Now | Beta Bionics | $29.72 | -5.79% | → $28 | Initiates | → Outperform | Get Alert | |
| 02/13/2025 | TXG | Buy Now | 10x Genomics | $15.75 | -23.81% | $25 → $12 | Downgrade | Outperform → Market Perform | Get Alert | |
| 02/11/2025 | INSP | Buy Now | Inspire Medical Systems | $119.26 | 62.67% | $193 → $194 | Maintains | Market Perform | Get Alert | |
| 10/25/2024 | DXCM | Buy Now | DexCom | $65.73 | 32.36% | $90 → $87 | Maintains | Outperform | Get Alert | |
| 09/10/2024 | INSP | Buy Now | Inspire Medical Systems | $119.26 | 65.19% | $167 → $197 | Maintains | Market Perform | Get Alert | |
| 09/03/2024 | TXG | Buy Now | 10x Genomics | $15.75 | 122.22% | → $35 | Initiates | → Outperform | Get Alert | |
| 09/03/2024 | PEN | Buy Now | Penumbra | $309.15 | -14.93% | → $263 | Initiates | → Outperform | Get Alert | |
| 09/03/2024 | NARI | Buy Now | Inari Medical | — | — | → $47 | Initiates | → Market Perform | Get Alert | |
| 04/25/2024 | TNDM | Buy Now | Tandem Diabetes Care | $21.41 | 110.18% | $34 → $45 | Upgrade | Market Perform → Outperform | Get Alert | |
| 04/08/2024 | SWAV | Buy Now | Shockwave Medical | — | — | $361 → $335 | Downgrade | Outperform → Market Perform | Get Alert | |
| 01/30/2024 | NPCE | Buy Now | NeuroPace | $15.92 | 38.19% | → $22 | Initiates | → Outperform | Get Alert | |
| 01/12/2024 | AXNX | Buy Now | Axonics | — | — | → $71 | Downgrade | Outperform → Market Perform | Get Alert | |
| 10/16/2023 | PODD | Buy Now | Insulet | $291.51 | -36.88% | → $184 | Initiates | → Outperform | Get Alert | |
| 10/16/2023 | VCEL | Buy Now | Vericel | $36.49 | 15.1% | → $42 | Initiates | → Outperform | Get Alert | |
| 10/16/2023 | ISRG | Buy Now | Intuitive Surgical | $559.52 | -38.88% | → $342 | Initiates | → Outperform | Get Alert | |
| 10/16/2023 | TNDM | Buy Now | Tandem Diabetes Care | $21.41 | -1.92% | → $21 | Initiates | → Market Perform | Get Alert | |
| 10/16/2023 | INSP | Buy Now | Inspire Medical Systems | $119.26 | 33.32% | → $159 | Initiates | → Market Perform | Get Alert | |
| 10/16/2023 | SWAV | Buy Now | ShockWave Medical | — | — | → $263 | Initiates | → Outperform | Get Alert | |
| 10/16/2023 | EW | Buy Now | Edwards Lifesciences | $83.78 | -10.48% | → $75 | Initiates | → Market Perform | Get Alert | |
| 10/16/2023 | DXCM | Buy Now | DexCom | $65.73 | 67.35% | → $110 | Initiates | → Outperform | Get Alert | |
| 10/16/2023 | PRCT | Buy Now | PROCEPT BioRobotics | $36.10 | 2.49% | → $37 | Initiates | → Outperform | Get Alert | |
| 10/16/2023 | AXNX | Buy Now | Axonics | — | — | → $70 | Initiates | → Outperform | Get Alert | |
| 10/16/2023 | AXGN | Buy Now | Axogen | $29.78 | -69.78% | → $9 | Initiates | → Outperform | Get Alert | |
| 08/15/2023 | GLTO | Buy Now | Galecto | $31.68 | -93.69% | $13 → $2 | Downgrade | Outperform → Market Perform | Get Alert | |
| 01/24/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.26 | 3471.43% | $33 → $45 | Maintains | Outperform | Get Alert | |
| 12/20/2022 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -43.81% | $145 → $315 | Maintains | Outperform | Get Alert | |
| 12/16/2022 | AXLA | Buy Now | Axcella Health | — | — | $6 → $2 | Downgrade | Outperform → Market Perform | Get Alert | |
| 12/15/2022 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -63.82% | $26 → $31 | Maintains | Market Perform | Get Alert | |
| 11/04/2022 | IMVT | Buy Now | Immunovant | $26.00 | -46.15% | $12 → $14 | Maintains | Outperform | Get Alert | |
| 08/15/2022 | VRDN | Buy Now | Viridian Therapeutics | $33.03 | 21.1% | $32 → $40 | Maintains | Outperform | Get Alert | |
| 08/11/2022 | RAPT | Buy Now | RAPT Therapeutics | $30.01 | 59.95% | $49 → $48 | Maintains | Outperform | Get Alert | |
| 08/03/2022 | GLTO | Buy Now | Galecto | $31.68 | -58.96% | $16 → $13 | Maintains | Outperform | Get Alert | |
| 07/20/2022 | PLRX | Buy Now | Pliant Therapeutics | $1.26 | 2519.05% | → $33 | Initiates | → Outperform | Get Alert | |
| 07/20/2022 | KYMR | Buy Now | Kymera Therapeutics | $85.68 | -69.65% | → $26 | Initiates | → Market Perform | Get Alert | |
| 07/20/2022 | MORF | Buy Now | Morphic Holding | — | — | → $45 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved